Mirum Pharmaceuticals (MIRM) is down -16.5%, or -$17.93 to $90.69.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIRM:
- Mirum Pharmaceuticals price target raised to $130 from $123 at Morgan Stanley
- Mirum Pharmaceuticals price target raised to $117 from $115 at TD Cowen
- Mirum Pharmaceuticals price target lowered to $128 from $130 at RBC Capital
- Mirum Pharmaceuticals price target raised to $125 from $98 at Stifel
- Mirum Pharmaceuticals: Livmarli-Driven Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating